ERBB2 and breast carcinoma: Breast cancer tissues included in the TMA analysis were classified into luminal A (297 cases, 41.9%), luminal B (168 cases, 23.7%), HER-2 (70 cases, 9.9%), or TNBC (174 cases, 24.5%; Table 2).